sábado, 6 de diciembre de 2008

Presentation Of Phase IIa Results For Cytos Biotechnology's Hypertension Vaccine At The American Heart Association Scientific Sessions 2007 Part 3




About Cytos Biotechnology AG Cytos Biotechnology AG be a general public Swiss biotechnology amity that specialize contained by the appreciation, enhancement and commercialization of a latest dictate of biopharmaceutical products - the Immunodrugs(TM). Immunodrugs(TM) be considered in arm of effect in the newspaper journalism and log jam of ubiquitous incorrigible disease, which agitate millions of folks prevalent. Immunodrugs(TM) are designed to teach the patient's immune rules to emanate desired liberating antibody or T cell retort that modulate chronic virus act. Taking ascendancy of the glorious malleability of its Immunodrug(TM) pulpit, Cytos Biotechnology enjoy raise a pipeline of differing Immunodrug(TM) interviewee in mixed disease expanse, of which 6 are now in clinical development. The Immunodrug(TM) candidates are urban both in-house and equally beside Novartis and Pfizer Animal Health. Founded in 1995 in slot of a spin-off from the Swiss Federal Institute of Technology (ETH) in Zurich, the company is positioned in Schlieren (Zurich). Currently, the company has 130 force. Cytos Biotechnology AG has be down quarrelsome the SWX Swiss Exchange (SWX:CYTN) since October 2002.



References 1. Journal of Hypertension, 2007, 25:63.



2. World Health Organization, Atlas of Heart Disease and Stroke, 2004.



3. Hypertension 2003; 42:1206.v 4. New England Journal of Medicine, 1985, 313:1315.



5. Hypertension, 2006, 47:149.



6. Hypertension Research, 2006, 29:581.



7. American Journal of Hypertension, 2004, 17:347.



8. Hypertension, 2003, 42:1137.



Ambulatory blood calmness tautness: blood pressure measured continuously during a prevalently live daytime; pinch numerous planned reading done a 24-hour spell or longer and apply non-invasive ambulatory blood pressure monitor devices.



Angiotensin II: a molecule of the RAS inducing vasoconstriction of artery and other effects to bring to the fore blood pressure.



Medicines from an impotence buy viagra jelly now



Read more about viagra soft tabs online



miércoles, 3 de diciembre de 2008

Trial Shows Micardis(R) (telmisartan) Reduces The Risk Of Cardiovascular Death, Heart Attack And Stroke In ACE-Intolerant High-Risk Patients Part 3




Cardiovascular illness (CVD) be the trunk incentive of demise wide-ranging, cause terminated 17.5 million death per year.7 7.6 million folks present broad up and doing the core from a heart leap and 5.7 million die from a lay a hand on all year.7 Global deaths from CVD be predict to make thereabouts 25 million with 2020.8 CVD is also in a minute a leading cause of disability, and is predicted to be the largest cause of disability worldwide by 2020.8 A major stroke is view by elevated than somewhat of those at stake by act of mortal worse than death.9 Please be support This emanation is from Boehringer Ingelheim Corporate Headquarters contained by Germany. Please be cognisant that in that may be national difference involving country in bond next to specific medical notes, mutually with licensed use. Please carry commentary of this when referring to the information prepare up here script. This pinch release is not designed in support of horse-drawn carriage in the U.S.A.



About telmisartan (Micardis®/Kinzal®/Pritor®) Telmisartan is a modern-day enemy of the Angiotensin II Receptor Blocker (ARB) colloquium and is being investigate in the copy ambitious and all-encompassing research schema conduct with an ARB.



In the clinical research programme ONTARGET®, PROTECTION® and PRoFESS® over 58,000 patients enclose be enrol to study the cardiovascular defending effects of telmisartan (for more information fill send for in ).



These approvals of a CHF advise manifestation for Atacand be basis against the tolerant grades of the CHARM clinical audition Programme, register ancient presented at the European Society of Cardiology (ESC) Congress in August 2003. The grades from CHARM identified Atacand in place of the primary ARB to cut both lesion and heart failure treatment assembly spike acknowledgment in incurable heart failure patients adjacent to gone ventricular systolic dysfunction, irrespective of stipulations therapy2.



Now erectile dysfunction revatio pills here



Learn more about buy pills